Topic: On 2 February 2022, the MRCT Center will host the second “Advancing international pediatric clinical research” conference, focusing on incorporating the perspectives of young people and the adults who care for them in clinical research and product development. The webinar will be hosted twice, from 9-11 am EST and 8-10 pm EST, with similar content but different speakers and panelists, to allow for wide attendance and global participation. Stay tuned for further details!
Topic: On 2 February 2022, the MRCT Center will host the second “Advancing international pediatric clinical research” conference, focusing on incorporating the perspectives of young people and the adults who care for them in clinical research and product development. The webinar will be hosted twice, from 9-11 am EST and 8-10 pm EST, with similar content but different speakers and panelists, to allow for wide attendance and global participation. Stay tuned for further details!
EQUITY BY DESIGN IN CLINICAL RESEARCH: CANCER TRIALS is a virtual training course communicating an understanding of, and training on best practices for, diversity, equity, and inclusion (DEI) of underrepresented populations in clinical trials. The course is intended to aid cancer centers in improving their ability to enroll underrepresented participants in clinical research and to develop mechanisms for ongoing sustainability of DEI in clinical research. Ethical and regulatory considerations will be included, and practical guidance for commitment, communication, partnership, and conduct will be emphasized. CME credit available.
MODULE 1: COMMITMENT TO DEI
Commitment to DEI will describe the grounds for institutional and individual commitment to diversity, equity, and inclusion in clinical research, and illustrate how to substantiate commitment with actions, metrics, and resources.
Hosted by The Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, The Center for Cancer Equity and Engagement at Dana-Farber/Harvard Cancer Center, and Mass General Brigham.
EQUITY BY DESIGN IN CLINICAL RESEARCH: CANCER TRIALS is a virtual training course communicating an understanding of, and training on best practices for, diversity, equity, and inclusion (DEI) of underrepresented populations in clinical trials. The course is intended to aid cancer centers in improving their ability to enroll underrepresented participants in clinical research and to develop mechanisms for ongoing sustainability of DEI in clinical research. Ethical and regulatory considerations will be included, and practical guidance for commitment, communication, partnership, and conduct will be emphasized. CME credit available.
MODULE 2: COMMUNITY ENGAGEMENT AND REPRESENTATION
Community Engagement and Representation will focus upon the importance of open, respectful, and clear communication throughout the community engagement and trial process; practical strategies for implementing and sustaining community and stakeholder engagement; and consideration for the complexity of data that needs to be interoperable, appropriately defined, and representative of diverse communities.
Hosted by The Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, The Center for Cancer Equity and Engagement at Dana-Farber/Harvard Cancer Center, and Mass General Brigham.
EQUITY BY DESIGN IN CLINICAL RESEARCH: CANCER TRIALS is a virtual training course communicating an understanding of, and training on best practices for, diversity, equity, and inclusion (DEI) of underrepresented populations in clinical trials. The course is intended to aid cancer centers in improving their ability to enroll underrepresented participants in clinical research and to develop mechanisms for ongoing sustainability of DEI in clinical research. Ethical and regulatory considerations will be included, and practical guidance for commitment, communication, partnership, and conduct will be emphasized. CME credit available.
MODULE 3: STUDY PLANNING AND COMMUNICATIONS
Study Planning and Communications will describe how to optimize the study question, design, and communications for diversity, equity, and inclusion in cancer clinical research. The impact of study design, eligibility criteria, feasibility assessment, site selection, decentralization of trials, and health literate and linguistically appropriate communications on recruitment and retention of underrepresented populations will be discussed.
Hosted by The Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, The Center for Cancer Equity and Engagement at Dana-Farber/Harvard Cancer Center, and Mass General Brigham.
EQUITY BY DESIGN IN CLINICAL RESEARCH: CANCER TRIALS is a virtual training course communicating an understanding of, and training on best practices for, diversity, equity, and inclusion (DEI) of underrepresented populations in clinical trials. The course is intended to aid cancer centers in improving their ability to enroll underrepresented participants in clinical research and to develop mechanisms for ongoing sustainability of DEI in clinical research. Ethical and regulatory considerations will be included, and practical guidance for commitment, communication, partnership, and conduct will be emphasized. CME credit available.
MODULE 4: STUDY CONDUCT
Study Conduct will emphasize components of study conduct and post-trial commitments to address barriers in participation and trust.
Hosted by The Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, The Center for Cancer Equity and Engagement at Dana-Farber/Harvard Cancer Center, and Mass General Brigham.
EQUITY BY DESIGN IN CLINICAL RESEARCH: CANCER TRIALS is a virtual training course communicating an understanding of, and training on best practices for, diversity, equity, and inclusion (DEI) of underrepresented populations in clinical trials. The course is intended to aid cancer centers in improving their ability to enroll underrepresented participants in clinical research and to develop mechanisms for ongoing sustainability of DEI in clinical research. Ethical and regulatory considerations will be included, and practical guidance for commitment, communication, partnership, and conduct will be emphasized. CME credit available.
MODULE 5: WORKFORCE DEVELOPMENT
Workforce Development will consider strategies for fostering recruitment, professional growth, and retention of a clinical research workforce representative of intended participant populations in clinical trials.
Hosted by The Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, The Center for Cancer Equity and Engagement at Dana-Farber/Harvard Cancer Center, and Mass General Brigham.
EQUITY BY DESIGN IN CLINICAL RESEARCH: CANCER TRIALS is a virtual training course communicating an understanding of, and training on best practices for, diversity, equity, and inclusion (DEI) of underrepresented populations in clinical trials. The course is intended to aid cancer centers in improving their ability to enroll underrepresented participants in clinical research and to develop mechanisms for ongoing sustainability of DEI in clinical research. Ethical and regulatory considerations will be included, and practical guidance for commitment, communication, partnership, and conduct will be emphasized. CME credit available.
MODULE 6: ACCOUNTABILITY, ADVOCACY, AND JUSTICE
Accountability, Advocacy and Justice describes processes for incorporating monitoring, review, accountability, and transparency, and considers opportunities for action both to uphold commitments and to advance equity by design in cancer clinical research.
Hosted by The Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, The Center for Cancer Equity and Engagement at Dana-Farber/Harvard Cancer Center, and Mass General Brigham.
The practice of returning IRR is consistently identified by participants as something that participants not only desire but also expect. Returning IRR demonstrates participant-centricity and respect.
A taskforce was convened during 2021 to update and further develop the MRCT Center’s guidance on Returning Individual Research Results to Participants – these resources and tools are ready to be shared, on a new, easy-to-navigate, dedicated website.
This one-hour webinar will include a review of IRR and its importance, a patient advocate describing her own lived experience with IRR, and a live demonstration of the new tools and website.
